Literature DB >> 24077440

The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.

Jimmy Belotte1, Nicole M Fletcher, Awoniyi O Awonuga, Mitchell Alexis, Husam M Abu-Soud, Mohammed G Saed, Michael P Diamond, Ghassan M Saed.   

Abstract

OBJECTIVE: To investigate the role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer (EOC).
METHODS: Two parent EOC cell lines (MDAH-2774 and SKOV-3) and their chemoresistant counterparts (cisplatin, 50 µmol/L) were used. Total RNA was extracted and subjected to real-time reverse transcriptase polymerase chain reaction to evaluate the expression of glutathione reductase (GSR) and inducible nitric oxide synthase (iNOS), as well as nitrate/nitrite levels. Analysis of variance was used for main effects and Tukey for post hoc analysis at P < .05 for statistical significance.
RESULTS: Both cisplatin resistant cell lines displayed a significant decrease in GSR messenger RNA (mRNA) levels and activity (P < .01). As compared to sensitive controls, nitrate/nitrite levels were significantly higher in SKOV-3 cisplatin resistant cells while iNOS mRNA levels were significantly higher in MDAH-2774 cisplatin resistant cells (P < .05).
CONCLUSION: Our data suggest that the development of cisplatin resistance tilts the balance toward a pro-oxidant state in EOC.

Entities:  

Keywords:  cisplatin resistance; epithelial ovarian cancer; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 24077440      PMCID: PMC3960837          DOI: 10.1177/1933719113503403

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  37 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Redox regulation of cellular signalling.

Authors:  H Kamata; H Hirata
Journal:  Cell Signal       Date:  1999-01       Impact factor: 4.315

3.  Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.

Authors:  D Randall Armant; Brian A Kilburn; Anelia Petkova; Samuel S Edwin; Zophia M Duniec-Dmuchowski; Holly J Edwards; Roberto Romero; Richard E Leach
Journal:  Development       Date:  2006-01-11       Impact factor: 6.868

Review 4.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 5.  Oxidative stress and cancer: have we moved forward?

Authors:  Barry Halliwell
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

6.  The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.

Authors:  John M Malone; Ghassan M Saed; Michael P Diamond; Robert J Sokol; Adnan R Munkarah
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

7.  Glutathione metabolism and glutathione S-conjugate export ATPase (MRP1/GS-X pump) activity in cancer. I. Differential expression in human cancer cell lines.

Authors:  P I de Bittencourt Júnior; R Curi; J F Williams
Journal:  Biochem Mol Biol Int       Date:  1998-09

8.  Modulation of human glutathione s-transferases by polyphenon e intervention.

Authors:  H-H Sherry Chow; Iman A Hakim; Donna R Vining; James A Crowell; Margaret E Tome; James Ranger-Moore; Catherine A Cordova; Dalia M Mikhael; Margaret M Briehl; David S Alberts
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

Review 9.  The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?

Authors:  Miguel López-Lázaro
Journal:  Anticancer Agents Med Chem       Date:  2008-04       Impact factor: 2.505

10.  Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.

Authors:  E L Leung; M Fraser; R R Fiscus; B K Tsang
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

View more
  12 in total

1.  Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts.

Authors:  Kathinka E Pitman; Santosh R Alluri; Alexander Kristian; Eva-Katrine Aarnes; Heidi Lyng; Patrick J Riss; Eirik Malinen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-01       Impact factor: 9.236

2.  Evaluation of Thiol/Disulfide Homeostasis in Lung Cancer.

Authors:  Melahat Uzel Şener; Özlem Sönmez; İhsan Atila Keyf; Özcan Erel; Murat Alışık; Sertan Bulut; Yurdanur Erdoğan
Journal:  Turk Thorac J       Date:  2020-07

3.  Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress.

Authors:  Xiaoyin Meng; Hongguang Chen; Guolin Wang; Yonghao Yu; Keliang Xie
Journal:  Exp Ther Med       Date:  2015-10-05       Impact factor: 2.447

4.  Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer.

Authors:  Leda Severi; Lorena Losi; Sergio Fonda; Laura Taddia; Gaia Gozzi; Gaetano Marverti; Fulvio Magni; Clizia Chinello; Martina Stella; Jalid Sheouli; Elena I Braicu; Filippo Genovese; Angela Lauriola; Chiara Marraccini; Alessandra Gualandi; Domenico D'Arca; Stefania Ferrari; Maria P Costi
Journal:  Front Pharmacol       Date:  2018-05-08       Impact factor: 5.810

5.  Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.

Authors:  Zining Jin; Wenqian Wang; Nan Jiang; Lei Zhang; Yiming Li; Xiaoyin Xu; Shouliang Cai; Liang Wei; Xuhong Liu; Guanglei Chen; Yizhen Zhou; Cheng Liu; Zhan Li; Feng Jin; Bo Chen
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 6.  Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis.

Authors:  Josep Marí-Alexandre; Antonio Pellín Carcelén; Cristina Agababyan; Andrea Moreno-Manuel; Javier García-Oms; Silvia Calabuig-Fariñas; Juan Gilabert-Estellés
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

7.  PD-0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance.

Authors:  Minghui Liu; Liyuan Cui; Xin Li; Chunqiu Xia; Yongwen Li; Rui Wang; Fan Ren; Hongyu Liu; Jun Chen
Journal:  Thorac Cancer       Date:  2021-02-03       Impact factor: 3.500

8.  Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells.

Authors:  Vidhya Tangeda; Yu Kang Lo; Ananth Ponneri Babuharisankar; Han-Yu Chou; Cheng-Liang Kuo; Yung-Hsi Kao; Alan Yueh-Luen Lee; Jang-Yang Chang
Journal:  Cell Death Dis       Date:  2022-03-16       Impact factor: 9.685

Review 9.  The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.

Authors:  Rina Masadah; Syahrul Rauf; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

Review 10.  The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.

Authors:  Fatemeh Rezaei-Tazangi; Hossein Roghani-Shahraki; Mahdi Khorsand Ghaffari; Firoozeh Abolhasani Zadeh; Aynaz Boostan; Reza ArefNezhad; Hossein Motedayyen
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.